Order Article Reprints

Wilson LL, Eans SO, Ramadan-Siraj I, Modica MN, Romeo G, Intagliata S, McLaughlin JP. Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use. International Journal of Molecular Sciences. 2022; 23(2):615. https://doi.org/10.3390/ijms23020615

Wilson, Lisa L., Shainnel O. Eans, Insitar Ramadan-Siraj, Maria N. Modica, Giuseppe Romeo, Sebastiano Intagliata, and Jay P. McLaughlin. 2022. "Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use" International Journal of Molecular Sciences 23, no. 2: 615. https://doi.org/10.3390/ijms23020615

Wilson, L. L., Eans, S. O., Ramadan-Siraj, I., Modica, M. N., Romeo, G., Intagliata, S., & McLaughlin, J. P. (2022). Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use. International Journal of Molecular Sciences, 23(2), 615. https://doi.org/10.3390/ijms23020615